Reconnect Labs

📍 Winterthur, Switzerland🗓 Founded 2021👥 8 employees💰 Last funded Aug 2021
Research Services🌐 reconnect-labs.com
Website LinkedIn
Reconnect Labs is a Swiss, clinical stage pharmaceutical company developing Regenerative Therapeutics™ for mental health at the forefront of neuroscience and precision psychopharmacology. Led by neuroscientists from the University of Zurich Psychiatric University Clinic (PUKZH), Reconnect translates 30 years of in-human research and clinical practice to solve for the safety, efficacy and commercialization challenges of generation 1 psychoplastogens, Reconnect originated a portfolio of psychoactive formulations for affective and neurodegenerative disorders, chronic pain and insomnia.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Reconnect Labs?
Reconnect Labs has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Reconnect Labs last raise funding?
The most recent investment in Reconnect Labs recorded on gritt.io was in August 2021.
When was Reconnect Labs founded?
Reconnect Labs was founded in 2021.
What industry is Reconnect Labs in?
Reconnect Labs operates in Research Services. Find similar Research Services investors on gritt.io.
Where is Reconnect Labs based?
Reconnect Labs is headquartered in Winterthur, Switzerland.